Impact of the endocrine disruptor DEHP on adipose tissue functio

Recruiting

• Conditions: Metabolic syndrome; E88.9; E65-E68; Metabolic disorder, unspecified; Obesity and other hyperalimentation

• Registration Number: DRKS00015703
• Lead Sponsor: Institut für Anatomie und Zellbiologie der MLU Halle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-11-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

orthopedic surgeries of the spine, patient agreement declaration

Exclusion Criteria

infectious diseases (MRSA, HIV, HepB/C), diabetes, Thyroid diseases, cancer, cachexia, no patient agreement declaration

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
primary cell culture/ adipose tissue culture; Exposure to DEHP and isolation of mRNA and protein for expression analyses of adipocyte markers.